Immunotherapy News and Research

Latest Immunotherapy News and Research

Immunotherapy that uses existing cancer drugs in a new way delivers promising results

Immunotherapy is an emerging field in the global fight against cancer, even though scientists and clinicians have been working for decades to find ways to help the body's immune system detect and attack cancerous cells.

29 Aug 2017

Extensive analysis reveals immune system dynamics after stem cell transplantation in leukemia patients

By combining new system-biological analyses and advanced data analysis, researchers at Karolinska Institutet have been able to monitor the maturation process of the immune system of leukemia patients who have undergone stem cell transplantation.

29 Aug 2017

Review highlights significant progress in developing new biologic drugs to treat colorectal cancer

New biologic drugs, such as monoclonal antibodies and immunotherapies in clinical development, designed to target metastatic colorectal cancer (CRC) and stimulate the immune system to destroy tumor cells are a significant advance in treatment over conventional chemotherapy.

29 Aug 2017

Immune booster could improve effectiveness of vaccines and cancer immunotherapy

Vaccines and cancer immunotherapies do essentially the same thing: They boost a person's immune system, better enabling it to fight an offender, be it microbe or malignancy.

29 Aug 2017

Simultaneous treatment with anti-PD1 and anti-OX40 cancer therapies may have detrimental effect

Concurrent administration of the T-cell stimulating anti-OX40 antibody and the immune checkpoint inhibitor anti-PD1 antibody attenuated the effect of anti-OX40 and resulted in poor treatment outcomes in mice.

28 Aug 2017

LSU Health New Orleans receives $10 million grant to support research on virus-induced cancers

The National Institute of General Medical Sciences has awarded LSU Health New Orleans a $10 million grant over five years to support new basic research studies advancing the development new diagnostic and therapeutic approaches for virus-induced cancers.

26 Aug 2017

Scientists develop new chimeric antibody to treat malignant cancers in dogs

Scientists have developed a new chimeric antibody that suppresses malignant cancers in dogs, showing promise for safe and effective treatment of intractable cancers.

26 Aug 2017

NIH grant for CWRU professors could enable new directions for cancer immunotherapies

Nicole Steinmetz, PhD, Associate Professor of Biomedical Engineering, Radiology, member of the Case Comprehensive Cancer Center and the Center for RNA Science and Therapeutics in the Division of General Medical Sciences at Case Western Reserve University School of Medicine and the holder of the George J. Picha Designated Professor in Biomaterials, has received a major grant from the National Institutes of Health to help understand how a virus-like particle from plants stimulates potent anti-tumor responses.

26 Aug 2017

Symptoms, triggers of food intolerance found to be similar in animals and humans

People are not the only ones suffering from the symptoms and problems of food intolerance and allergies.

23 Aug 2017

Combination treatment effectively vaccinates mice against cancer

By combining an FDA-approved cancer immunotherapy with an emerging tumor-roasting nanotechnology, Duke University researchers improved the efficacy of both therapies in a proof-of-concept study using mice.

18 Aug 2017

Study provides evidence that oral immunotherapy may be possible cure for peanut allergy

Allergy immunotherapy company Prota Therapeutics Pty Ltd is pleased to announce results from a follow up study of the probiotic and peanut immunotherapy (PPOIT) treatment which it has licensed from the Murdoch Childrens Research Institute, demonstrating long-lasting tolerance effects of treatment more than four years after the original study ended.

18 Aug 2017

Peanut allergy successfully kept at bay with immune-based therapy

Australian researchers from the Murdoch Children’s Research Institute have come up with a latest study results showing that peanut allergy could be treated successfully with an immune-based therapy. This new therapy helped children allergic to peanuts eat these nuts with no reactions for up to four years. The study appeared this week in the journal Lancet Child & Adolescent Health.

17 Aug 2017

Sanford Health launches solid tumor oncolytic virus clinical trial

Sanford Health is the first site in the United States to launch a clinical trial using a genetically-engineered virus that aims to destroy therapy-resistant tumors.

17 Aug 2017

Immunotherapy drug shows favorable safety profile in patients with advanced small cell lung cancer

The immunotherapy drug pembrolizumab has demonstrated a favorable safety profile and "promising durable clinical activity" in pretreated patients who exhibit high levels of the PD-L1 protein in advanced stages of small cell lung cancer (SCLC) – an aggressive form of the disease

16 Aug 2017

Blood biopsy helps identify targetable genetic alterations in patients with cancer of unknown primary

Using fragments of circulating tumor DNA in blood, University of California San Diego School of Medicine researchers were able to identify theoretically targetable genetic alterations in 66 percent of patients with cancer of unknown primary (CUP), a rare disease with seven to 12 cases per 100,000 people each year.

16 Aug 2017

Alternative medicine use instead of proven cancer therapies results in worse survival

Patients who choose to receive alternative therapy as treatment for curable cancers instead of conventional cancer treatment have a higher risk of death, according to researchers from the Cancer Outcomes, Public Policy and Effectiveness Research Center at Yale School of Medicine and Yale Cancer Center.

11 Aug 2017

Fred Hutch aims to prevent and find cures for cancers caused by infectious agents

Fred Hutchinson Cancer Research Center is launching a new integrated research center to prevent and find cures for cancers caused by infectious agents.

10 Aug 2017

Immunotherapy shows promise in treatment of Type 1 diabetes

Around 1.25 million Americans are living with type 1 diabetes and 40,000 new cases are detected each year. In this condition body’s own immune system attacks and damages the insulin-producing β-cells inside the pancreas leading to impaired glucose metabolism in the body. There is no other treatment for this condition than regular painful insulin injections to maintain the normal insulin levels in the body. Type 1 diabetes is currently considered to be incurable.

10 Aug 2017

Promising brain cancer vaccine developed at Roswell Park receives orphan drug status from FDA

The U.S. Food and Drug Administration has awarded orphan drug status to a promising immunotherapy vaccine developed at Roswell Park Cancer Institute.

8 Aug 2017

Tackling food allergies: is immunotherapy the answer?

Food allergies affect approximately 8% of school children in the United States and the United Kingdom. The highest prevalence of food allergies is in Australia affecting approximately 10% of young children. It is lower in the developing world.

7 Aug 2017

Immunotherapy News and Research

Latest Immunotherapy News and Research

Immunotherapy that uses existing cancer drugs in a new way delivers promising results

Extensive analysis reveals immune system dynamics after stem cell transplantation in leukemia patients

Review highlights significant progress in developing new biologic drugs to treat colorectal cancer

Immune booster could improve effectiveness of vaccines and cancer immunotherapy

Simultaneous treatment with anti-PD1 and anti-OX40 cancer therapies may have detrimental effect

LSU Health New Orleans receives $10 million grant to support research on virus-induced cancers

Scientists develop new chimeric antibody to treat malignant cancers in dogs

NIH grant for CWRU professors could enable new directions for cancer immunotherapies

Symptoms, triggers of food intolerance found to be similar in animals and humans

Combination treatment effectively vaccinates mice against cancer

Study provides evidence that oral immunotherapy may be possible cure for peanut allergy

Peanut allergy successfully kept at bay with immune-based therapy

Sanford Health launches solid tumor oncolytic virus clinical trial

Immunotherapy drug shows favorable safety profile in patients with advanced small cell lung cancer

Blood biopsy helps identify targetable genetic alterations in patients with cancer of unknown primary

Alternative medicine use instead of proven cancer therapies results in worse survival

Fred Hutch aims to prevent and find cures for cancers caused by infectious agents

Immunotherapy shows promise in treatment of Type 1 diabetes

Promising brain cancer vaccine developed at Roswell Park receives orphan drug status from FDA

Tackling food allergies: is immunotherapy the answer?

eBook: The Ultimate Guide to Successful Immunofluorescence eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Immunotherapy News and Research

Latest Immunotherapy News and Research

eBook: The Ultimate Guide to Successful Immunofluorescence eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in